Key Points:
- The Asia-Pacific advanced drug delivery market is expected to reach USD 22,252 million in 2032, with a CAGR of 12% from 2023 to 2032.
- The North America region was estimated at USD 24,624.2 million in 2022 and is expected to grow at a CAGR of 10% from 2023 to 2032.
- The nanocarriers segment was valued at USD 36,537.1 million in 2022.
- The hospital segment was accounted USD 27,224.3 million in 2022.
- The specialty clinics segment is expected to grow at a CAGR of 11.3% from 2023 to 2032.
- North America accounted largest market share of 40% in 2022.
Get the Free Sample Copy of Report@ https://www.precedenceresearch.com/sample/1877
Constant research and development activities have helped in coming up with innovative products if the bucket in the form of injectables. Growing demand for self administration of drugs will drive the market growth in this region. Growth in the geriatric population and increased number of chronic diseases in the United States will also drive the market growth. There has been no large number of deaths due to many chronic diseases like the cardiovascular diseases as well as cancer. Increase in the number of deaths due to these diseases is also expected to drive the market during the forecast period. A large number of people in the North American region suffer with diabetes.
The number of people suffering with diabetes is expected to grow in the coming years. This is will create a great demand for the use of advanced drug delivery systems integrating all of these diseases. The key market players are major manufacturers constantly focusing on coming off different compounds that will be more efficient in delivering the drugs. Large number of acquisitions as well as collaborations in the market players will provide good opportunities for growth during the forecast period.
Report highlights
- On the basis of the type, the oral drug delivery system is expected to have the largest market share in the coming years. As this form happens to be a convenient way the patients as well as the physicians prefer it. It reduces the possibilities of the toxicity of the drugs and it also reduces the side effects. There has been a growth in the research and development activities for developing oral drug delivery systems as it is in great demand. This method is flexible and does not require a high frequency of doses.
- By end user, the hospital segment will grow with the highest compound annual growth rate during the forecast period. The growth of this segment is attributed to the availability of expert professionals and advanced healthcare infrastructure. The availability of reimbursement policies are also expected to drive the market growth. the specialty clinic segment had dominated the market in the past.
- On the basis of the product, the nanocarrier segment will dominate the market in the coming years. Due to the efficient targeting of the organ which is affected due to a disease in the human beings The market for nanocarriers is expected to grow in the coming years.
- The North American region will dominate the market due to the presence of major market players in this region. As that as we know increase the amount of adoption of the drug delivery systems in this region the revenue is expected to grow. Increased amount of disposable income has led to an increased expenditure on the health care services in the North American region especially in the United States.
Report Scope of the Advanced Drug Delivery Market
| Report Coverage | Details |
| Market Size in 2023 | USD 67.22 Billion |
| Market Size by 2032 | USD 247.8 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 15.60% |
| North America Market Share in 2022 | 40% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Type, Product Type, End User, Geography |
Advanced Drug Delivery Market dynamics
Drivers
As there has been an increase in the investments by the government as well as the major market players for the research and development activities the market is expected to grow during the forecast period. This research focuses on the development of biologics as well as the new products that will be helpful and efficient did reading different diseases. These research and development activities have also provided a better understanding of the human body which happens to be an important factor in devising various drug delivery systems. It has also helped in understanding the facts the body cues of the patients suffering with different diseases. And it provides great opportunity through this understanding. It is also extremely helpful in coming up with novel drugs for the treatment of these diseases. Research organisations have come up with different types of drug delivery systems like the polymer technologies and the lipid technology. There is also adult in the use of protein technology as it is extremely beneficial in maintaining the quality of the drug. It prevents the degradation of the drug which often happens due to its interference with the environment. the advanced drug delivery system provides better action by selecting a specific site and the market is expected to grow as this mode is easier and requires limited number of doses.
Restraints
The Use of nanoparticles for drug delivery happens to have many risks associated with its use. It may sometimes prove to be toxic for the brain. Apart from the toxicity of nanoparticles or the nanotechnology other concern is the stability of the particles. The use of nanoparticles may also affect the organs of the human being.
Opportunities
Recently there have been many developments in providing many successful drug delivery systems that make use of active compounds of the natural type. Increased use of micro-particles for treating cancer which has proven to be extremely beneficial and efficient. Companies are focusing on providing novel molecules to increase the benefits. Growth in the use of nanoparticles for delivering the drugs at a precise location is expected to provide great opportunities for growth in the future.
Challenges
As there are not a lot of products available in the market the competition amongst the already existing market players is tough. The stringent regulatory policies that lead to the failure and introduction of various drugs in the market happen to be major challenge in the growth of the market. There are a few limitations associated with the technology when it comes to developing different methods for delivery of the drug. The use of advanced products for treating various diseases is expensive. This health care facility is not accessible in many countries that come into the low income group.
Read Also: Artificial Intelligence (AI) In Drug Discovery Market Size Report by 2032
Key market developments
Becton, Dickinson and company, will set up a manufacturing unit for the drug delivery devices in Spain. This company shall invest an amount of U.S. dollars 200 million for developing the facility.
Advanced Drug Delivery Market Companies
- Baxter
- Boston Scientific Corporation
- AbbVie Inc.
- Becton, Dickinson and Company
- Kindeva Drug Delivery L.P
- Bausch Health Companies Inc.
- Novo Nordisk A/S
- Ocular Therapeutix, Inc.
- 3M
- Raphas Co., Ltd.
- GALDERMA
- NanoPass
- Altaris
- Micropoint Technologies
- Takeda Pharmaceutical Company Limited
Segments Covered in the Report
By Type
- Oral
- Inhalation
- Carrier
- Injection
- Targeted
- Others
By Product Type
- Nanocarriers
- Micro Needle Patch
- Hydrogel
- Drug Eluting Lens
By End User
- Hospitals
- Specialized clinics
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/